Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

Drug resistance in breast cancer (BC) cells continues to be a stern obstacle hindering BC treatment. Adriamycin (ADR) is a frequently employed chemotherapy agent used to treat BC. The exosomal transfer of microRNAs (miRNAs) has been reported to enhance the drug-resistance of BC cells. Herein, we fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xiaoping, Hong, Xiaolv, Lai, Jinguo, Cheng, Lu, Cheng, Yandong, Yao, Mingmei, Wang, Rong, Hu, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212418/
https://www.ncbi.nlm.nih.gov/pubmed/32426266
http://dx.doi.org/10.3389/fonc.2020.00441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212418/
https://www.ncbi.nlm.nih.gov/pubmed/32426266
http://dx.doi.org/10.3389/fonc.2020.00441

Ejemplares similares